Occlusion Therapy
Ophthalmologists and Optometrists alike embrace Occlusion
Therapy as one of the most effective treatments for Dry
Eye Syndrome (Dry Eye) and related Tear System Dysfunction. It
is the second most common ophthalmic procedure performed by
eye doctors, only after refraction for eyeglasses or contact
lenses.
Occlusion Therapy is achieved through placement of dissolvable
or non-dissolvable lacrimal or punctal plugs helping to preserve
the natural, good quality, lubricating tears on the surface
of the eyes. This treatment is especially beneficial in patients
unable to receive adequate symptomatic relief from lubricating
eye drops. Occlusion Therapy can also enhance the effectiveness
of topically applied ocular lubricants and medications, as
well as reduce their systemic side effects.
The Herrick System™ of Occlusion Therapy was developed
by Robert S. Herrick, M.D. in the 1980’s and has become
a world-wide recognized treatment for Dry Eye.
Robert S. Herrick,
MD
Dr.
Herrick is a corneal, external disease, and oculoplastics specialist
with offices in Palm Springs and Lake Ellsinore, California,
USA. He is the world's foremost leader in the field of Occlusion
Therapy for patients with Dry Eye Syndrome (Dry Eye) and related
Tear System Dysfunction.
As a young boy in New Mexico, in the 1940's, Dr. Herrick suffered
from Dry Eye. He was treated with a refillable prescription
for cortico-steroid eye drops and beta radiation treatments,
yet continued to suffer with the symptoms. He began his medical
career as a general practitioner and after ten years, with
the persistence of his Dry Eye condition, decided to sub-specialize
in Ophthalmology. He became a corneal specialist, specifically
with the desire to remedy his own problem.
In the late 1970's, Dr. Herrick found that many doctors reserved
a Dry Eye diagnosis for patients with only very extreme conditions.
At that time electric cautery was the only method available
to close the tear drains, so Occlusion
Therapy was maintained
as a treatment of last resort. Dr. Herrick discovered that
some patients were being treated for Dry Eye at some of the
larger academic institutions such as UCLA and USC, but were
not getting the help they needed and were often told that there
was nothing that could be done.
Out of his compulsion to help these patients, Dr. Herrick
began researching ways to preserve the natural lubricating
tears on the eye’s surface. First he pioneered and patented
the “Temporary Stitch Test” which involved using
a nylon suture to close the tear drain for about a week. If
the patients Dry Eye symptoms improved during this test period,
the doctor could proceed with electric cautery with greater
confidence. As an improvement over electric cautery, Dr. Herrick
invented and patented the Argon Laser Canaliculoplasty procedure
in the late 1970s.
As more and more people experienced the Temporary Stitch Test
(TST) prior to electric cautery or laser canaliculoplasty,
Dr. Herrick noticed that many Dry Eye patients also experienced
improvement of secondary non-ocular symptoms involving nasal
and sinus congestion, post-nasal-drip, chronic cough and headaches
.
As an improvement over the Temporary Stitch Test (which required
an injection of anesthetic) Dr. Herrick went on to develop
and patent the dissolvable Collagen Plugs which are used by
many clinicians today in the Lacrimal
Efficiency Test™. The
dissolvable collagen test plugs meant that children and adults
could temporarily experience the benefits of Occlusion Therapy
prior to having medium or long-term Occlusion Therapy performed.
In 1984 Dr. Herrick founded Lacrimedics,
Inc. so that these
important products for Occlusion Therapy, and related training
information, could be disseminated to physicians and patients
throughout the world. Today, Dr. Herrick’s son, Robert
Herrick II runs Lacrimedics, and continues to promote and
develop the Herrick System™ of
Occlusion Therapy. This comprehensive system has evolved to
include dissolvable and non-dissolvable intracanalicular plugs
for short, medium, and long-term Occlusion Therapy in Dry Eye
patients, and those with related Tear System Dysfunction.
Philosophically, Dr. Herrick's drive is to make the world a better place and
to become a better person. This is reflected in his commitment to medicine,
research and his patients. Dr. Herrick conducts research into technically advanced
procedures for eye care and provides information to the lay public through
the Herrick Research Institute (HRI). He continues to actively develop other
concepts besides plug patents, such as intra-ocular, intra-corneal, contact
lens systems, and refractive therapy patents for current technology. He interfaces
with patients who have extenuating circumstances or complex circumstances around
their care, and is dedicated to finding solutions.
Recent Papers by Dr. Herrick:
LACRIMAL
SYSTEM DYSFUNCTION AND RESULTANT NEUROIMMUNE DYSREGULATION, “Clinical
Lacrimology” by Robert S. Herrick, MD (46.kB Microsoft
Word.doc)
Download
a free Word Viewer here (12
MB, for .doc files)
In the spring of 2006, Dr. Robert Herrick
delivered a series of enthusiastically received
presentations to the 6th International Congress of Ophthalmology
and Optometry China in Shanghai, China. Then, in Hangzhou,
China, speaking to hundreds of Chinese Ophthalmologists at
a Corneal Congress, Dr. Herrick presented a foundational understanding
of the relationship between Lacrimal System Dysfunction and
corneal disease.
Extrapolating from his clinical experience in successful treatment
of dry eye and other conditions caused by Lacrimal System Dysfunction,
Herrick proposed a new line of research to establish causal
connections between Lacrimal System Dysfunction and chronic
states he terms Chronic Parasympathetic Dominance and Neuro-Immune
Dysregulation. He theorized that this is the root cause of
many common diseases, and that correcting the lacrimal system
dysfunction provides Ophthalmologists with an effective and
efficient protocol that provides tremendous, affordable relief
to their patients.
How to Consult with
Dr. Herrick:
Physicians may reach Dr. Herrick for consultation through
his private practices in Southern California.
Robert S. Herrick, M.D.
C/O Mission Optical
32245 Mission Trail, Suite D4
Lake Elsinore, CA 92530
Tel: (951) 674-1561
Fax: (951) 674-5300
or
Robert S. Herrick, M.D.
C/O Evans Eye Care
44250 Town Center Way, Suite C10
Palm Desert, CA 92260
Tel: (760) 674-8806
Fax: (760) 674-8826
|